Tandem Diabetes Care, Inc.
General ticker "TNDM" information:
- Sector: Health Care
- Industry: Medical - Devices
- Capitalization: $1.4B (TTM average)
Tandem Diabetes Care, Inc. follows the US Stock Market performance with the rate: 14.2%.
Estimated limits based on current volatility of 2.6%: low 20.67$, high 21.76$
Factors to consider:
- Total employees count: 2650 (+10.4%) as of 2024
- US accounted for 71.5% of revenue in the fiscal year ended 2024-12-31
- Top business risk factors: Manufacturing risks, Market competition, Cost increases, Geopolitical risks, Labor/talent shortage/retention
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [15.62$, 36.60$]
- 2026-12-31 to 2027-12-31 estimated range: [14.08$, 33.60$]
Financial Metrics affecting the TNDM estimates:
- Negative: with PPE of -15.2 at the end of fiscal year the price was high
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -0.65 <= 0.01
- Positive: Investing cash flow per share per price, % of 4.84 > -0.63
Short-term TNDM quotes
Long-term TNDM plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $747.72MM | $940.20MM | $1,014.74MM |
| Operating Expenses | $980.95MM | $1,039.33MM | $1,092.86MM |
| Operating Income | $-233.23MM | $-99.13MM | $-78.12MM |
| Non-Operating Income | $12.98MM | $7.26MM | $-122.15MM |
| Interest Expense | $9.88MM | $7.42MM | $7.91MM |
| R&D Expense | $248.42MM | $198.88MM | $174.84MM |
| Income(Loss) | $-220.25MM | $-91.87MM | $-200.27MM |
| Taxes | $2.36MM | $4.16MM | $4.44MM |
| Profit(Loss)* | $-222.61MM | $-96.03MM | $-204.71MM |
| Stockholders Equity | $313.63MM | $263.10MM | $155.17MM |
| Inventory | $157.94MM | $149.61MM | $128.77MM |
| Assets | $952.66MM | $967.66MM | $881.11MM |
| Operating Cash Flow | $-31.81MM | $24.23MM | $-9.72MM |
| Capital expenditure | $26.80MM | $19.23MM | $19.95MM |
| Investing Cash Flow | $-85.74MM | $-23.48MM | $72.88MM |
| Financing Cash Flow | $4.11MM | $8.37MM | $-43.37MM |
| Earnings Per Share** | $-3.43 | $-1.47 | $-3.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.